Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pazopanib in Salivary Gland Carcinoma
NCT02393820Phase 2Completed
- Sponsor
- Unicancer
- Start
- Aug 2013
- Primary completion
- Dec 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of pazopanib in salivary gland carcinoma (SGC), sponsored by Unicancer. Started Aug 2013; status: completed.
02
Drugs
pazopanib
03
Conditions
salivary gland carcinoma (SGC)
Beyond the preview
Go deeper on NCT02393820.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02393820.